EcoDrugPlus

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSCDRG00005002282
Gene Symbol: CYP46A1
3 Cross references
260 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSCDRG00005016963
Gene Symbol: DGAT1
1 Cross references
262 Possible Orthologues:

Dihydrofolate Reductase

Ensembl ID : ENSCDRG00005018379
Gene Symbol: DHFR
2 Cross references
352 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSCDRG00005007318
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSCDRG00005001178
Gene Symbol: DPYD
1 Cross references
228 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSCDRG00005003991
Gene Symbol: DDR2
3 Cross references
264 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSCDRG00005004119
Gene Symbol: DRD1
3 Cross references
262 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSCDRG00005012244
Gene Symbol: DRD2
3 Cross references
222 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSCDRG00005012896
Gene Symbol: DRD3
3 Cross references
209 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSCDRG00005008371
Gene Symbol: DRD4
1 Cross references
245 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSCDRG00005021005
Gene Symbol: DRD5
1 Cross references
164 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSCDRG00005012530
Gene Symbol: EGLN1
1 Cross references
239 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).